PMID: 18706263DOI: 10.1007/s11912-008-0057-0Aug 19, 2008Paper
Modern approaches to treating chronic myelogenous leukemia.
Current Oncology Reports
Javier Pinilla-Ibarz, Celeste Bello
Abstract
Over the past decade, the treatment of chronic myelogenous leukemia (CML) has gone through significant advances. Once an invariably fatal disease without stem cell transplant, it has since become one of the most manageable hematologic malignancies with good long-term outcomes. However, patients are not cured and require life-long treatment, and unfortunately, some of these patients develop resistant disease that progresses despite our best treatments. As our understanding of CML continues to grow, the repertoire of drugs available for successful treatment also increases. The following review discusses the current and future therapies for CML.
References
Mar 2, 1990·Science·T G LugoO N Witte
Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Jul 6, 2000·Current Opinion in Hematology·J G JurcicD A Scheinberg
Sep 30, 2000·Blood Reviews·J Pinilla-IbarzD A Scheinberg
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·E A Nigg
Jun 26, 2001·Science·M E GorreC L Sawyers
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
May 3, 2002·Blood·Charles L SawyersBrian J Druker
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Sep 25, 2003·Blood·Kathleen CathcartDavid A Scheinberg
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Feb 11, 2005·Leukemia·D MarinJ F Apperley
Feb 22, 2005·Lancet·M BocchiaF Lauria
Jun 3, 2005·Cancer Research·Thomas O'HareBrian J Druker
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mirna GolemovicMiloslav Beran
Mar 21, 2006·Leukemia Research·Haruna NaitoKazuko Hirabayashi
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Jun 16, 2006·The New England Journal of Medicine·Hagop KantarjianOliver G Ottmann
Jul 28, 2006·Current Opinion in Immunology·Sylvie Rusakiewicz, Jeffrey J Molldrem
Sep 7, 2006·Blood·Asumi YokotaTaira Maekawa
Sep 23, 2006·Blood·Francis J GilesSteven J Freedman
Sep 23, 2006·Leukemia·J Pinilla-IbarzD A Scheinberg
Nov 23, 2006·Cancer Research·Miriam PuttiniCarlo Gambacorti-Passerini
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
Feb 24, 2007·Blood·Hagop KantarjianNeil Shah
May 15, 2007·Blood·Oliver OttmannSteven Coutre
Jun 21, 2007·Blood·Lijun ShenGopesh Srivastava
Jul 11, 2007·TheScientificWorldJournal·Yoshihiro OkaHaruo Sugiyama
Jul 13, 2007·Blood·Elias JabbourJorge Cortes
Jul 20, 2007·Leukemia·J M RojasR E Clark
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rena J MayDavid A Scheinberg
Aug 24, 2007·Blood·Hagop M KantarjianPhilipp le Coutre
Sep 6, 2007·Blood·Jorge CortesDan Jones
Sep 19, 2007·Blood·Katayoun RezvaniA John Barrett
Dec 1, 2007·Blood·Philipp le CoutreHagop Kantarjian
Dec 25, 2007·Blood·Mhairi CoplandTessa L Holyoake
Feb 8, 2008·Leukemia·P G MaslakD A Scheinberg
❮ Previous
Next ❯
Citations
Aug 13, 2009·Cancer Causes & Control : CCC·Lau Caspar ThygesenChristoffer Johansen
Feb 12, 2014·Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology·Shweta Bansal, S H Advani
Aug 21, 2013·TheScientificWorldJournal·Ihsan Yıkılgan, Oya Bala
Oct 23, 2010·Expert Opinion on Drug Delivery·Bhupender S Chhikara, Keykavous Parang
Mar 9, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Ai-Mei LiaoChangJu Chun
❮ Previous
Next ❯
Related Concepts
Related Feeds
Related Papers
Biochemical Pharmacology
A M BergmanG J Peters
Cancer
Elias JabbourHagop M Kantarjian
Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting
(opens in new tab)Journal of Pharmaceutical Sciences
Fujun LiTom Alfredson
European Journal of Medicinal Chemistry
Boyang LiuGuohui Cui
Molecular Pharmaceutics
Yongbing SunZhonggui He